
Reset all filters
01 2Izervay
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 36
2022 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Ophthalmology
Currency : USD
2024 Revenue in Millions : 330
2023 Revenue in Millions : 40
Growth (%) : 718